Mono- and biallelic variant effects on disease at biobank scale

H. O. Heyne (), J. Karjalainen, K. J. Karczewski, S. M. Lemmelä, W. Zhou, A. S. Havulinna, M. Kurki, H. L. Rehm, A. Palotie and M. J. Daly ()
Additional contact information
H. O. Heyne: University of Helsinki
J. Karjalainen: University of Helsinki
K. J. Karczewski: University of Helsinki
S. M. Lemmelä: University of Helsinki
W. Zhou: University of Helsinki
A. S. Havulinna: University of Helsinki
M. Kurki: University of Helsinki
H. L. Rehm: Broad Institute of MIT and Harvard
A. Palotie: University of Helsinki
M. J. Daly: University of Helsinki

Nature, 2023, vol. 613, issue 7944, 519-525

Abstract: Abstract Identifying causal factors for Mendelian and common diseases is an ongoing challenge in medical genetics1. Population bottleneck events, such as those that occurred in the history of the Finnish population, enrich some homozygous variants to higher frequencies, which facilitates the identification of variants that cause diseases with recessive inheritance2,3. Here we examine the homozygous and heterozygous effects of 44,370 coding variants on 2,444 disease phenotypes using data from the nationwide electronic health records of 176,899 Finnish individuals. We find associations for homozygous genotypes across a broad spectrum of phenotypes, including known associations with retinal dystrophy and novel associations with adult-onset cataract and female infertility. Of the recessive disease associations that we identify, 13 out of 20 would have been missed by the additive model that is typically used in genome-wide association studies. We use these results to find many known Mendelian variants whose inheritance cannot be adequately described by a conventional definition of dominant or recessive. In particular, we find variants that are known to cause diseases with recessive inheritance with significant heterozygous phenotypic effects. Similarly, we find presumed benign variants with disease effects. Our results show how biobanks, particularly in founder populations, can broaden our understanding of complex dosage effects of Mendelian variants on disease.

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41586-022-05420-7 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:613:y:2023:i:7944:d:10.1038_s41586-022-05420-7

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/s41586-022-05420-7

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().